AAAAAA
Results: 1-25/29
Authors:
BLOWER SM
GERBERDING JL
Citation: Sm. Blower et Jl. Gerberding, UNDERSTANDING, PREDICTING AND CONTROLLING THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS - A THEORETICAL FRAMEWORK, Journal of molecular medicine, 76(9), 1998, pp. 624-636
Authors:
GERBERDING JL
Citation: Jl. Gerberding, NOSOCOMIAL TRANSMISSION OF OPPORTUNISTIC INFECTIONS, Infection control and hospital epidemiology, 19(8), 1998, pp. 574-577
Authors:
BLOCH KC
ZWERLING L
PLETCHER MJ
HAHN JA
GERBERDING JL
OSTROFF SM
VUGIA DJ
REINGOLD AL
Citation: Kc. Bloch et al., INCIDENCE AND CLINICAL IMPLICATIONS OF ISOLATION OF MYCOBACTERIUM-KANSASII - RESULTS OF A 5-YEAR, POPULATION-BASED STUDY, Annals of internal medicine, 129(9), 1998, pp. 698
Authors:
KATZ MH
GERBERDING JL
Citation: Mh. Katz et Jl. Gerberding, PROPHYLAXIS AFTER SEXUAL EXPOSURE TO HIV - RESPONSE, Annals of internal medicine, 129(8), 1998, pp. 672-672
Authors:
KATZ MH
GERBERDING JL
Citation: Mh. Katz et Jl. Gerberding, THE CARE OF PERSONS WITH RECENT SEXUAL EXPOSURE TO HIV, Annals of internal medicine, 128(4), 1998, pp. 306-312
Authors:
GERBERDING JL
Citation: Jl. Gerberding, AMINOGLYCOSIDE DOSING - TIMING IS OF THE ESSENCE, The American journal of medicine, 105(3), 1998, pp. 256-258
Authors:
HENDERSON DK
CHIARELLO LA
DICKINSON GM
FRASER VJ
GERBERDING JL
GREAVES WL
MAYER KH
RHAME FS
TAPPER ML
WEINSTEIN RA
Citation: Dk. Henderson et al., MANAGEMENT OF HEALTH-CARE WORKERS INFECTED WITH HEPATITIS-B VIRUS, HEPATITIS-C VIRUS, HUMAN-IMMUNODEFICIENCY-VIRUS, OR OTHER BLOODBORNE PATHOGENS, Infection control and hospital epidemiology, 18(5), 1997, pp. 349-363
Authors:
GERBERDING JL
Citation: Jl. Gerberding, OCCUPATIONAL HIV-INFECTION, AIDS, 11, 1997, pp. 57-60
Authors:
KATZ MH
GERBERDING JL
Citation: Mh. Katz et Jl. Gerberding, POSTEXPOSURE TREATMENT OF HIV - REPLY, The New England journal of medicine, 337(7), 1997, pp. 501-501
Authors:
KATZ MH
GERBERDING JL
Citation: Mh. Katz et Jl. Gerberding, POSTEXPOSURE TREATMENT OF PEOPLE EXPOSED TO THE HUMAN-IMMUNODEFICIENCY-VIRUS THROUGH SEXUAL CONTACT OR INJECTION-DRUG USE, The New England journal of medicine, 336(15), 1997, pp. 1097-1100
Authors:
RAMOSGOMEZ F
ELLISON J
GREENSPAN D
BIRD W
LOWE S
GERBERDING JL
Citation: F. Ramosgomez et al., ACCIDENTAL EXPOSURES TO BLOOD AND BODY-FLUIDS AMONG HEALTH-CARE WORKERS IN DENTAL TEACHING CLINICS - A PROSPECTIVE-STUDY, The Journal of the American Dental Association, 128(9), 1997, pp. 1253-1261
Authors:
EVANS SE
FAHRNER R
GERBERDING JL
Citation: Se. Evans et al., HIV, HBV, AND HCV PREVALENCE AMONG SOURCE PATIENTS (SP) REPORTED TO THE SAN-FRANCISCO GENERAL-HOSPITAL (SFGH) NEEDLESTICK HOTLINE, Clinical infectious diseases, 23(4), 1996, pp. 24-24
Authors:
BEEKMANN SE
FAHRNER R
GERBERDING JL
KOZIOL D
HENDERSON DK
Citation: Se. Beekmann et al., RISK-FACTORS FOR HIV SEROCONVERSION IN A PROSPECTIVE-STUDY OF ZIDOVUDINE (ZDV) POSTEXPOSURE PROPHYLAXIS (PEP), Clinical infectious diseases, 23(4), 1996, pp. 26-26
Authors:
WEBB ML
PERDREAUREMINGTON F
HADLEY WK
GERBERDING JL
Citation: Ml. Webb et al., PROSPECTIVE EVALUATION OF CLONAL DIVERSITY OF CANDIDA-ALBICANS ISOLATED FROM THE OROPHARYNX OF HIV+ PATIENTS, Clinical infectious diseases, 23(4), 1996, pp. 223-223
Authors:
MARTIN JN
ROSE DA
HADLEY WK
PERDREAUREMINGTON F
GERBERDING JL
Citation: Jn. Martin et al., EMERGENCE OF TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE IN THE AIDS ERA, Clinical infectious diseases, 23(4), 1996, pp. 253-253
Authors:
BLOCH KC
GERBERDING JL
Citation: Kc. Bloch et Jl. Gerberding, SAMPLE-SIZE COULD LIMIT THE POWER OF CASE-CONTROL STUDIES FOR DETERMINING RISK-FACTORS FOR COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, Clinical infectious diseases, 23(4), 1996, pp. 851-851
Authors:
GERBERDING JL
Citation: Jl. Gerberding, TRANSMISSION OF HEPATITIS VIRUSES BY SURGEONS - REPLY, The New England journal of medicine, 335(4), 1996, pp. 286-287
Authors:
MARTIN JN
GERBERDING JL
OSMOND DH
Citation: Jn. Martin et al., TESTING FOR ANTIBODIES IN KAPOSIS-SARCOMA, The New England journal of medicine, 335(11), 1996, pp. 819-819
Authors:
GERBERDING JL
Citation: Jl. Gerberding, THE INFECTED HEALTH-CARE PROVIDER, The New England journal of medicine, 334(9), 1996, pp. 594-595
Authors:
GERBERDING JL
Citation: Jl. Gerberding, PROPHYLAXIS FOR OCCUPATIONAL EXPOSURE TO HIV, Annals of internal medicine, 125(6), 1996, pp. 497-501
Authors:
WOOLWINE JD
GERBERDING JL
Citation: Jd. Woolwine et Jl. Gerberding, EFFECT OF TESTING METHOD ON APPARENT ACTIVITIES OF ANTIVIRAL DISINFECTANTS AND ANTISEPTICS, Antimicrobial agents and chemotherapy, 39(4), 1995, pp. 921-923
Authors:
GERBERDING JL
LEWIS FR
SCHECTER WP
Citation: Jl. Gerberding et al., ARE UNIVERSAL PRECAUTIONS REALISTIC, The Surgical clinics of North America, 75(6), 1995, pp. 1091
Authors:
GERBERDING JL
QUEBBEMAN EJ
RHODES RS
Citation: Jl. Gerberding et al., HAND PROTECTION, The Surgical clinics of North America, 75(6), 1995, pp. 1133
Authors:
GERBERDING JL
Citation: Jl. Gerberding, DRUG-THERAPY - MANAGEMENT OF OCCUPATIONAL EXPOSURES TO BLOOD-BORNE VIRUSES, The New England journal of medicine, 332(7), 1995, pp. 444-451
Authors:
GERBERDING JL
Citation: Jl. Gerberding, THE FALSE-POSITIVE POLYMERASE CHAIN-REACTION AND THE OSTRICH - REPLY, The Journal of infectious diseases, 172(5), 1995, pp. 1421-1421